Search
Cardiolipin Biosynthesis CL(10:0/10:0/i-16:0/18:2(9Z,11Z))
smpdb.ca/view/SMP0175776MetabolicCardiolipin (CL) is an important component of the inner mitochondrial membrane where it constitutes about 20% of the total lipid composition.
Cardiolipin Biosynthesis CL(10:0/10:0/i-17:0/18:2(9Z,11Z))
smpdb.ca/view/SMP0175796MetabolicCardiolipin (CL) is an important component of the inner mitochondrial membrane where it constitutes about 20% of the total lipid composition.
Cardiolipin Biosynthesis CL(10:0/10:0/18:2(9Z,11Z)/i-22:0)
smpdb.ca/view/SMP0175528MetabolicCardiolipin (CL) is an important component of the inner mitochondrial membrane where it constitutes about 20% of the total lipid composition.
Cardiolipin Biosynthesis CL(10:0/10:0/a-13:0/18:2(9Z,11Z))
smpdb.ca/view/SMP0175589MetabolicCardiolipin (CL) is an important component of the inner mitochondrial membrane where it constitutes about 20% of the total lipid composition.
Cardiolipin Biosynthesis CL(10:0/10:0/i-12:0/18:2(9Z,11Z))
smpdb.ca/view/SMP0175672MetabolicCardiolipin (CL) is an important component of the inner mitochondrial membrane where it constitutes about 20% of the total lipid composition.
Cardiolipin Biosynthesis CL(10:0/10:0/i-13:0/18:2(9Z,11Z))
smpdb.ca/view/SMP0175702MetabolicCardiolipin (CL) is an important component of the inner mitochondrial membrane where it constitutes about 20% of the total lipid composition.
Cardiolipin Biosynthesis CL(10:0/10:0/i-14:0/18:2(9Z,11Z))
smpdb.ca/view/SMP0175729MetabolicCardiolipin (CL) is an important component of the inner mitochondrial membrane where it constitutes about 20% of the total lipid composition.
Cardiolipin Biosynthesis CL(10:0/10:0/i-18:0/18:2(9Z,11Z))
smpdb.ca/view/SMP0175813MetabolicCardiolipin (CL) is an important component of the inner mitochondrial membrane where it constitutes about 20% of the total lipid composition.
Lynestrenol
go.drugbank.com/drugs/DB12474ApprovedWithdrawnLynestrenol is a progestin and prodrug of norethisterone.
Products: ORGAMETRİL 5 MG TABLET, 30 ADETPRX-P4-003
go.drugbank.com/drugs/DB33967ExperimentalPRX-P4-003 is under investigation in clinical trial NCT04638803 (A Phase 0, Open-Label, Crossover Microdose Pharmacokinetic Study of PRX-P4-003 in Healthy Volunteers). … PRX-P4-003 is a small molecule drug.